FDA Approves Olumiant for Adolescents with Severe Alopecia Areata
FDA approves Olumiant (baricitinib) for patients aged 12 and older with severe…
FDA Approves Inluriyo and Verzenio Combination for Certain Advanced Breast Cancers
The FDA approves Inluriyo with Verzenio for certain ESR1-mutated advanced breast cancers…
Major Acquisition to Advance Therapies for Treatment-Resistant Depression
Lilly will acquire AtaiBeckley in a deal valued at up to $3.8…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer
Antag Therapeutics has appointed obesity treatment expert Philip Just Larsen as Chief…
Abu Dhabi Expands Access to Innovative Daily Oral Obesity Treatment
Abu Dhabi has expanded access to an innovative daily oral obesity treatment…
UAE: Emirates Drug Establishment approves oral obesity treatment
Emirates Drug Establishment, EDE UAE, orforglipron, Foundayo, Eli Lilly, oral obesity treatment,…
Saudi Arabia’s Riyadh to Host Landmark Life Sciences Summit in May 2026
Riyadh will host CPHI Middle East and BIO Middle East from May…
NVIDIA and Lilly Launch AI Co-Innovation Lab for Next-Generation Drug Discovery
NVIDIA and Lilly launch a $1 billion AI co-innovation lab in San…
Compliance Officer, Boehringer Ingelheim IMETA (India, Middle East, Turkey, Africa)
Hani Hussein is a seasoned compliance leader with over 25 years of…
